GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Level Biotechnology 3118.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

30.30

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 736.6m

FY2016FY2025

Net income

TWD 79.7m

FY2016FY2025

Free cash flow

TWD 26.9m

FY2016FY2025

Shareholders' equity

TWD 580.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 736.6mTWD 731.3mTWD 660.6mTWD 593.0mTWD 677.3mTWD 672.5mTWD 638.9mTWD 629.0mTWD 577.6mTWD 513.5m
Gross profitTWD 257.7mTWD 237.1mTWD 219.5mTWD 202.6mTWD 232.5mTWD 211.7mTWD 195.8mTWD 185.5mTWD 207.9mTWD 193.8m
Research and developmentTWD 13.7mTWD 13.0mTWD 13.8mTWD 14.0mTWD 15.0mTWD 13.7mTWD 13.6mTWD 13.6mTWD 11.9mTWD 13.7m
Operating incomeTWD 83.5mTWD 75.3mTWD 79.2mTWD 73.5mTWD 85.4mTWD 73.1mTWD 56.4mTWD 49.2mTWD 80.8mTWD 74.5m
Net incomeTWD 79.7mTWD 64.8mTWD 62.9mTWD 58.5mTWD 68.2mTWD 58.0mTWD 47.4mTWD 38.9mTWD 68.3mTWD 63.3m
Diluted earnings per share2.482.021.931.802.101.791.481.212.131.94

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 866.8mTWD 827.1mTWD 822.7mTWD 812.5mTWD 787.6mTWD 773.0mTWD 750.2mTWD 680.4mTWD 732.3mTWD 676.0m
Cash and short-term investments——TWD 467.4mTWD 463.5mTWD 473.0mTWD 380.3m———TWD 338.1m
Total liabilitiesTWD 286.6mTWD 267.2mTWD 273.2mTWD 270.1mTWD 242.8mTWD 243.6mTWD 236.4mTWD 181.6mTWD 210.0mTWD 160.5m
Debt——TWD 13.5mTWD 12.7mTWD 13.4mTWD 15.9m————
Shareholders' equityTWD 580.2mTWD 559.9mTWD 549.5mTWD 542.4mTWD 544.8mTWD 529.4mTWD 513.8mTWD 498.8mTWD 522.3mTWD 515.5m
Shares outstanding32m32m33m32m32m32m32m32m32m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 59.6mTWD 64.1mTWD 70.2mTWD 65.1mTWD 155.9mTWD 83.2mTWD 109.0mTWD 26.8mTWD 71.3mTWD 79.1m
Capital spending−TWD 32.7m−TWD 223.7m−TWD 7.7m−TWD 6.7m−TWD 9.2m−TWD 2.5m−TWD 2.4m−TWD 2.5m−TWD 10.8m−TWD 7.5m
Free cash flowTWD 26.9m−TWD 159.6mTWD 62.5mTWD 58.3mTWD 146.8mTWD 80.7mTWD 106.6mTWD 24.3mTWD 60.5mTWD 71.6m
Dividends paid−TWD 58.4m−TWD 55.2m−TWD 55.2m−TWD 61.7m−TWD 51.9m−TWD 42.2m−TWD 32.5m−TWD 61.7m−TWD 61.7m−TWD 71.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 162.4mTWD 158.9mTWD 188.0mTWD 200.1mTWD 171.6mTWD 176.9mTWD 204.7mTWD 182.2m
Gross profitTWD 55.0mTWD 59.5mTWD 65.8mTWD 76.9mTWD 59.9mTWD 55.1mTWD 65.5mTWD 59.3m
Operating incomeTWD 12.0mTWD 19.9mTWD 22.1mTWD 31.5mTWD 15.9mTWD 14.1mTWD 23.6mTWD 16.5m
Net incomeTWD 13.5mTWD 17.3mTWD 18.4mTWD 26.8mTWD 14.6mTWD 19.8mTWD 19.5mTWD 15.0m
Diluted earnings per share0.420.540.570.840.460.620.610.47
Cash from operationsTWD 45.0mTWD 13.0mTWD 33.0mTWD 11.0mTWD 5.0mTWD 8.0mTWD 53.0mTWD 21.0m
Capital spending——−TWD 10.0m−TWD 4.0m−TWD 15.0m−TWD 2.0m−TWD 221.0m−TWD 1.0m
Free cash flow——TWD 23.0mTWD 7.0m−TWD 10.0mTWD 6.0m−TWD 168.0mTWD 20.0m
Total assetsTWD 799.1mTWD 834.4mTWD 866.8mTWD 799.9mTWD 849.5mTWD 825.5mTWD 827.1mTWD 797.7m
Shareholders' equityTWD 539.6mTWD 597.5mTWD 580.2mTWD 562.8mTWD 536.0mTWD 579.8mTWD 559.9mTWD 539.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.5%1.8%3.5%
Operating income4.3%2.7%-0.2%
Net income10.9%6.5%0.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.7%33.7%33.4%33.8%
Operating margin10.8%11.4%11.5%11.7%
Net margin9.8%9.8%9.6%9.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.315.815.815.314.316.818.323.315.315.6
Price to sales1.41.41.51.51.41.41.41.41.81.9

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 12 Jun 2025.

FY2025FY2024FY2023FY2022
Paid in the year1.801.701.701.90
  • 1.05-for-1 split · 5 Aug 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.